Consolidated Planning Corp Mckesson Corp Transaction History

Consolidated Planning Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	BUY	$652.83 - $732.78 $148,845 - $167,073	228 Added 11.3%	2,246 $1.65 Million
Q1 2025 Apr 22, 2025	SELL	$566.21 - $672.99 $195,342 - $232,181	-345 Reduced 14.6%	2,018 $1.36 Million
Q4 2024 Jan 29, 2025	BUY	$482.27 - $628.5 $587,887 - $766,141	1,219 Added 106.56%	2,363 $1.35 Million
Q3 2024 Oct 31, 2024	BUY	$479.06 - $630.38 $142,280 - $187,222	297 Added 35.06%	1,144 $565,000
Q2 2024 Aug 02, 2024	BUY	$518.81 - $607.81 $143,191 - $167,755	276 Added 48.34%	847 $494,000

Q1 2024 May 02, 2024	BUY	$473.42 - $539.26 $270,322 - $307,917	571 New	571 $306,000
Q2 2023 Aug 14, 2023	BUY	$354.01 - $427.31 $187,625 - $226,474	530 New	530 $226,000

2,114

108M

1.02M

836K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $121B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Consolidated Planning Corp with notifications on news.